European Heart Journal Advance Access published online on November 11, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi618
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Interventional Cardiology Unit, St Raffaele Hospital, Milan, Italy; Institute of Medical Statistics and Biometrics, University of Milan, Milan, Italy
* To whom correspondence should be addressed. Aims Coronary dissections left untreated after percutaneous coronary intervention are associated with unfavourable outcomes. However, their role after drug-eluting stent (DES) implantation is still undescribed. We assessed incidence, predictors, and outcomes of residual dissections in DES-treated lesions. Methods and results Consecutive patients undergoing DES implantation were enrolled in four Italian centres, with baseline, procedural, and outcome data entered into a dedicated database. Residual dissections were classified according to the National Heart Lung and Blood Institute criteria. End-points of interest were in-hospital, 1-month, and 6-month major adverse cardiovascular events (MACE, i.e. death, myocardial infarction, or target vessel revascularization), and stent thrombosis (ST). Among the 2418 included patients (4630 lesions), a total of 77 (1.7%) final dissections occurred in 67 (2.8%) subjects. Dissections were more frequent in longer and complex lesions and in the left anterior descending, and were associated with increased rates of in-hospital (11.9 vs. 5.2%, P = 0.017) and 1-month MACE (13.4 vs. 6.0%, P = 0.013), with similar 6-month trends. Cumulative ST was also greater in patients with dissections (6.3 vs. 1.3%, P = 0.011). Even non-obstructive dissections with thrombolysis in myocardial infarction 3 flow conferred a significantly worse prognosis. Conclusion This study, reporting for the first time on incidence, predictors, and outcomes of residual dissections in DES-treated coronary lesions, demonstrates their adverse clinical impact and supports the pursuit of a strategy of sealing dissection flaps with other DES.
Received February 24, 2005
Revised August 29, 2005
Accepted October 6, 2005
Clinical research
Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation
2 Mediolanum Cardio Research, Milan, Italy; Department of Cardiology, AZ Middelheim, Antwerpen, Belgium
3 Mediolanum Cardio Research, Milan, Italy; EMO Centro Cuore Columbus, via Buonarroti 48, 20145 Milan, Italy
4 Interventional Cardiology Unit, St Raffaele Hospital, Milan, Italy
5 EMO Centro Cuore Columbus, via Buonarroti 48, 20145 Milan, Italy
6 Interventional Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
7 Interventional Cardiology, Azienda Ospedaliera Careggi, University of Florence, Florence, Italy
8 Mediolanum Cardio Research, Milan, Italy
9 Interventional Cardiology Unit, St Raffaele Hospital, Milan, Italy; EMO Centro Cuore Columbus, via Buonarroti 48, 20145 Milan, Italy
Antonio Colombo, E-mail: info{at}emocolumbus.it
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
X. Liu, K. Tsujita, A. Maehara, G. S. Mintz, G. Weisz, G. D. Dangas, A. J. Lansky, E. M. Kreps, L. E. Rabbani, M. Collins, et al. Intravascular Ultrasound Assessment of the Incidence and Predictors of Edge Dissections After Drug-Eluting Stent Implantation J. Am. Coll. Cardiol. Intv., October 1, 2009; 2(10): 997 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lagerqvist, J. Carlsson, O. Frobert, J. Lindback, F. Schersten, U. Stenestrand, S. K. James, and for the Swedish Coronary Angiography and Angioplas Stent Thrombosis in Sweden: A Report From the Swedish Coronary Angiography and Angioplasty Registry Circ Cardiovasc Interv, October 1, 2009; 2(5): 401 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Alfonso, M.-J. Perez-Vizcayno, M. Ruiz, A. Suarez, M. Cazares, R. Hernandez, J. Escaned, C. Banuelos, P. Jimenez-Quevedo, and C. Macaya Coronary aneurysms after drug-eluting stent implantation clinical, angiographic, and intravascular ultrasound findings. J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2053 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Windecker and B. Meier Late Coronary Stent Thrombosis Circulation, October 23, 2007; 116(17): 1952 - 1965. [Full Text] [PDF] |
||||
![]() |
R. Jaffe and B. H. Strauss Late and Very Late Thrombosis of Drug-Eluting Stents: Evolving Concepts and Perspectives J. Am. Coll. Cardiol., July 10, 2007; 50(2): 119 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G.L. Biondi-Zoccai, M. Lotrionte, P. Agostoni, A. Abbate, M. Fusaro, F. Burzotta, L. Testa, I. Sheiban, and G. Sangiorgi A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease Eur. Heart J., November 2, 2006; 27(22): 2667 - 2674. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Alfonso Residual coronary dissections after drug-eluting stenting: the good, the bad, and the ugly Eur. Heart J., March 1, 2006; 27(5): 503 - 505. [Full Text] [PDF] |
||||




